Suonpää JT - Search Results

1

In vivo model for frontal sinus and calvarial bone defect obliteration with bioactive glass S53P4 and hydroxyapatite.

Peltola MJ, Aitasalo KM, Suonpää JT, Yli-Urpo A, Laippala PJ. Peltola MJ, et al. Among authors: suonpaa jt. J Biomed Mater Res. 2001 May 1;58(3):261-9. doi: 10.1002/1097-4636(2001)58:3<261::aid-jbm1015>3.0.co;2-7. J Biomed Mater Res. 2001. PMID: 11319739

2

Bioactive glass S53P4 in frontal sinus obliteration: a long-term clinical experience.

Peltola M, Aitasalo K, Suonpää J, Varpula M, Yli-Urpo A. Peltola M, et al. Head Neck. 2006 Sep;28(9):834-41. doi: 10.1002/hed.20436. Head Neck. 2006. PMID: 16823870 Clinical Trial.

3

Frontal sinus and skull bone defect obliteration with three synthetic bioactive materials. A comparative study.

Peltola MJ, Aitasalo KM, Suonpää JT, Yli-Urpo A, Laippala PJ, Forsback AP. Peltola MJ, et al. Among authors: suonpaa jt. J Biomed Mater Res B Appl Biomater. 2003 Jul 15;66(1):364-72. doi: 10.1002/jbm.b.10023. J Biomed Mater Res B Appl Biomater. 2003. PMID: 12808596

4

Long-term microscopic and tissue analytical findings for 2 frontal sinus obliteration materials.

Peltola MJ, Aitasalo KM, Aho AJ, Tirri T, Suonpää JT. Peltola MJ, et al. Among authors: suonpaa jt. J Oral Maxillofac Surg. 2008 Aug;66(8):1699-707. doi: 10.1016/j.joms.2007.11.020. J Oral Maxillofac Surg. 2008. PMID: 18634960 No abstract available.

5

In vitro model for frontal sinus obliteration with bioactive glass S53P4.

Peltola MJ, Suonpää JT, Andersson H, Määttänen HS, Aitasalo KM, Yli-Urpo A, Laippala PJ. Peltola MJ, et al. Among authors: suonpaa jt. J Biomed Mater Res. 2000;53(2):161-6. doi: 10.1002/(sici)1097-4636(2000)53:2<161::aid-jbm5>3.0.co;2-3. J Biomed Mater Res. 2000. PMID: 10713562

6

Clinical follow-up method for frontal sinus obliteration with bioactive glass S53P4.

Peltola MJ, Suonpää JT, Määttänen HS, Varpula MJ, Aitasalo KM, Yli-Urpo A, Laippala PJ. Peltola MJ, et al. Among authors: suonpaa jt. J Biomed Mater Res. 2001;58(1):54-60. doi: 10.1002/1097-4636(2001)58:1<54::aid-jbm80>3.0.co;2-t. J Biomed Mater Res. 2001. PMID: 11152998

7

Obliteration of the frontal sinus cavity with bioactive glass.

Peltola M, Suonpää J, Aitasalo K, Varpula M, Yli-Urpo A, Happonen RP. Peltola M, et al. Head Neck. 1998 Jul;20(4):315-9. doi: 10.1002/(sici)1097-0347(199807)20:4<315::aid-hed6>3.0.co;2-1. Head Neck. 1998. PMID: 9588704

8

Experimental follow-up model for clinical frontal sinus obliteration with bioactive glass (S53P4).

Peltola M, Suonpää J, Aitasalo K, Määttänen H, Andersson O, Yli-Urpo A, Laippala P. Peltola M, et al. Acta Otolaryngol Suppl. 2000;543:167-9. doi: 10.1080/000164800454305. Acta Otolaryngol Suppl. 2000. PMID: 10909011

9

Operative treatment of frontal sinusitis.

Suonpää J, Sipilä J, Aitasalo K, Antila J, Wide K. Suonpää J, et al. Acta Otolaryngol Suppl. 1997;529:181-3. doi: 10.3109/00016489709124116. Acta Otolaryngol Suppl. 1997. PMID: 9288304

10

Recurrent and prolonged frontal sinusitis.

Wide K, Suonpää J, Laippala P. Wide K, et al. Clin Otolaryngol Allied Sci. 2004 Feb;29(1):59-65. doi: 10.1111/j.1365-2273.2004.00781.x. Clin Otolaryngol Allied Sci. 2004. PMID: 14961854

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page